Mallinckrodt details generic drug spin off, renames speciality drug company
May 28, 2019 at 11:50 AM EDT
As part of its spin-off plans, Mallinckrodt on Tuesday announced that its specialty brands company will be renamed Sonorant Therapeutics Plc. and retain constipation drug Amitiza.
